Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer

Abstract Metastatic cancers commonly activate adaptive chemotherapy resistance, attributed to both microenvironment‐dependent phenotypic plasticity and genetic characteristics of cancer cells. However, the contribution of chemotherapy itself to the non‐genetic resistance mechanisms was long neglecte...

Cijeli opis

Bibliografski detalji

Glavni autori:	Lidia Moyano‐Galceran, Elina A Pietilä, S Pauliina Turunen, Sara Corvigno, Elisabet Hjerpe, Daria Bulanova, Ulrika Joneborg, Twana Alkasalias, Yuichiro Miki, Masakazu Yashiro, Anastasiya Chernenko, Joonas Jukonen, Madhurendra Singh, Hanna Dahlstrand, Joseph W Carlson, Kaisa Lehti
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer Nature 2020-03-01
Serija:	EMBO Molecular Medicine
Teme:	chemotherapy EphA2 GPRC5A HGSC resistance
Online pristup:	https://doi.org/10.15252/emmm.201911177
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!